Patents by Inventor Mitchell Anthony DeLong

Mitchell Anthony DeLong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8618086
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: December 31, 2013
    Assignee: Duke University
    Inventors: Mitchell Anthony deLong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: 8541466
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: September 24, 2013
    Assignee: Duke University
    Inventors: Mitchell Anthony DeLong, John McMillan McIver, Robert Scott Youngquist
  • Publication number: 20090286769
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: August 4, 2009
    Publication date: November 19, 2009
    Applicant: DUKE UNIVERSITY
    Inventors: Mitchell Anthony DeLong, John McMillan McIver, Robert Scott Youngquist
  • Publication number: 20080241078
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: June 13, 2008
    Publication date: October 2, 2008
    Applicant: DUKE UNIVERSITY
    Inventors: Mitchell Anthony DeLong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: 7407987
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: August 5, 2008
    Assignee: Duke University
    Inventors: Mitchell Anthony deLong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: 7388029
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 17, 2008
    Assignee: Duke University
    Inventors: Mitchell Anthony DeLong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: 7115659
    Abstract: 2-Decarboxy-2-phosphinico prostaglandin derivatives are disclosed. These derivatives comprise a modified ?-chain and an ?-chain bonded to a ring structure. The modified ?-chain has a 2-decarboxy-2-phosphinico group. The derivatives can be used to treat a variety of pharmaceutical and cosmetic conditions.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: October 3, 2006
    Assignee: The Procter & Gamble Company
    Inventor: Mitchell Anthony DeLong
  • Patent number: 7074942
    Abstract: 2-Decarboxy-2-phosphinico prostaglandin derivatives are disclosed. These derivatives comprise a modified ?-chain and an ?-chain bonded to a ring structure. The modified ?-chain has a 2-decarboxy-2-phosphinico group. The derivatives can be used to treat a variety of pharmaceutical and cosmetic conditions.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: July 11, 2006
    Assignee: The Procter & Gamble Company
    Inventor: Mitchell Anthony deLong
  • Patent number: 6894175
    Abstract: 2-Decarboxy-2-phosphinico prostaglandin derivatives are disclosed. These derivatives comprise a modified ?-chain and an ?-chain bonded to a ring structure. The modified ?-chain has a 2-decarboxy-2-phosphinico group. The derivatives can be used to treat a variety of pharmaceutical and cosmetic conditions.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: May 17, 2005
    Assignee: The Procter & Gamble Company
    Inventor: Mitchell Anthony DeLong
  • Publication number: 20040131648
    Abstract: Novel and nonobvious compounds that function, alone or in combination, as nuclear hormone receptors for the stimulation and/or improvement of murine, mammalian skin. Specifically, beta-ionol analog and fatty acid analog compounds that are believed to function as RXR, RAR and/or PPAR receptor ligands to encourage skin differentiation and discourage excess skin proliferation. The present invention further relates to one or more products, consumer and otherwise, comprising the novel, nuclear hormone receptor ligands disclosed herein.
    Type: Application
    Filed: October 24, 2002
    Publication date: July 8, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Mitchell Anthony deLong, Scott Louis Cohen
  • Patent number: 6586463
    Abstract: Compounds having the general structure: which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: July 1, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Mitchell Anthony deLong, David Lindsey Soper, John August Wos, Biswanath De
  • Patent number: 6537527
    Abstract: This invention relates to compositions, compounds, and methods for lightening skin, using active compounds having the general structure: wherein each X is halo; m is 1 to 4; each R′ and R″ is independently selected from hydrogen, halo, C1-C10 alkyl, substituted C1-C10 alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, OR, OCOR, OCRROR, COR, CR(OR)OR, CONRR, COOR, CRROR, CN, SR, and NRR; each R is selected from hydrogen, C1-C10 alkyl, substituted C1-C10 alkyl, substituted or unsubstituted phenyl, and substituted or unsubstituted naphthyl; n is 1 to 5; Z is O; in an amount effective to lighten skin; and a pharmaceutically-acceptable carrier therefor.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: March 25, 2003
    Assignee: Children's Hospital Medical Center
    Inventors: Kalla Lynn Kvalnes, Mitchell Anthony DeLong, Barton James Bradbury, Curtis Bobby Motley, John David Carter
  • Publication number: 20020146439
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandins analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: January 31, 2001
    Publication date: October 10, 2002
    Inventors: Mitchell Anthony DeLong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: 6451859
    Abstract: Compounds having a structure according to the following formula: are effective in treating disorders such as bone disorders and glaucoma in a subject in need thereof.
    Type: Grant
    Filed: August 29, 2001
    Date of Patent: September 17, 2002
    Assignee: The Procter & Gamble Company
    Inventors: Mitchell Anthony deLong, David Lindsey Soper, John August Wos, Biswanath De
  • Patent number: 6444840
    Abstract: The invention provides novel prostaglandin analogs. In particular, the present invention relates to compounds having a structure according to formula (I) wherein R1, R2, R3, R4, R5, R6, W, X, Z, a, b, p and q are defined below. This invention also includes optical isomers, diastereomers and enantiomers of formula (I), and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders and glaucoma. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders and glaucoma using these compounds or the compositions containing them.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: September 3, 2002
    Assignee: The Procter & Gamble Co.
    Inventors: Mitchell Anthony deLong, Jack Snyder Amburgey, Jr., John August Wos, Biswanath De, David Lindsey Soper
  • Patent number: 6410780
    Abstract: The invention provides novel prostaglandin analogs. In particular, the present invention relates to compounds having a structure according to formula (I) wherein R1, R2, R3, R4, R5, R6, W, X, Z, a, b, p and q are defined below. This invention also includes optical isomers, diastereomers and enantiomers of formula (I), and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders and glaucoma. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders and glaucoma using these compounds or the compositions containing them.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: June 25, 2002
    Assignee: The Procter & Gamble Co.
    Inventors: Mitchell Anthony deLong, Jack Snyder Amburgey, Jr., John August Wos, Biswanath De, David Lindsey Soper
  • Patent number: 6372730
    Abstract: The invention provides novel Prostaglandin F analogs. In particular, the present invention is directed to compounds having a structure according to the following formula: wherein R1, R2, X, Y, V, a, b, W, and Z are defined below. This invention also includes optical isomers, diastereomers and enantiomers of the formula above, and pharmaceutically—acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders and glaucoma. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders and glaucoma using these compounds or the compositions containing them.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: April 16, 2002
    Assignee: The Procter & Gamble Company
    Inventors: Mitchell Anthony deLong, John August Wos, Biswanath De, Frank Hallock Ebetino
  • Publication number: 20020037913
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: September 4, 2001
    Publication date: March 28, 2002
    Inventors: Mitchell Anthony deLong, David Lindsey Soper, John August Wos, Biswanath De
  • Publication number: 20020037914
    Abstract: A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
    Type: Application
    Filed: January 31, 2001
    Publication date: March 28, 2002
    Inventors: Mitchell Anthony Delong, John McMillan McIver, Robert Scott Youngquist
  • Patent number: RE43372
    Abstract: Compounds having the general structure: which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: May 8, 2012
    Assignee: Duke University
    Inventors: Mitchell Anthony deLong, David Lindsey Soper, John August Wos, Biswanath De